楚世峰导师简介

个人简介:
楚世峰,男,1981年9月出生,毕业于北京协和医学院。博士,副研究员,山西中医药大学硕士生导师。先后主持科研项目5项,发表论文30余篇,其中中文核心(或SCI)论文28篇,出版专著10部。
研究学科(领域):中医基础理论
研究方向:中医脑病学
在研项目:
1. 三七通过抑制CKLF1减少免疫血栓形成发挥脑中风治疗特色的物质基础与作用机制研究(U2202214),国家自然科学基金联合基金项目,2023.01-2026.12,240万元,主持
2. 扶正类中药调控衰老功效与配伍的科学表征及机理研究(2022YFC3500301),国家重点研发计划,2022.12-2025.12,480万元,主持
3. 人参皂苷Rg1通过抑制CKLF1调控小胶质细胞功能变化治疗脑中风的机制研究(82074044),国家自然科学基金面上项目,2021.01-2024.12,55万元,主持
代表性成果:
Wang Hong-yun#, Ye Jun-rui#, Peng Ye, Ma Wen-yu, Chen Hao-dong, Sun Hong-shuo, Feng Zhong-ping, He Wen-bin, Li Gang, Chu Shi-feng*, Zhang Zhao*, Chen Nai-hong*. CKLF induces microglial activation via triggering defective mitophagy and mitochondrial dysfunction. Autophagy. 2024, 20(3):590-613.
Ma Wen-yu, Wu Qing-lin, Wang Sha-sha, Wang Hong-yun, Ye Jun-rui, Sun Hong-shuo, Feng Zhong-ping, He Wen-bin, Chu Shi-feng*, Zhang Zhao*, Chen Nai-hong*. A breakdown of metabolic reprogramming in microglia induced by CKLF1 exacerbates immune tolerance in ischemic stroke. Journal of neuroinflammation. 2023, 20:97.
Peng Ye, Ye Jun-rui, Wang Sha-sha, He Wen-bin, Feng Zhong-ping, Sun Hong-shuo, Chu Shi-feng*, Zhang Zhao*, Chen Nai-hong*. A small molecule 20C from Gastrodia elata inhibits α-synuclein aggregation and prevents progression of Parkinson’s disease. Cell death &disease.2023, 594:14.
Wu Qing-lin, Cui Li-yuan, Ma Wen-yu, Wang Sha-sha, Zhang Zhao, Feng Zhong-ping, Sun Hong-shuo, Chu Shi-feng*, He Wen-bin*, Chen Nai-hong*. A small molecular antagonist of CCR5 promoted neural repair post stroke. Acta Pharmacol Sin. 2023, 44(10):1935-1947.
He Jia-qi, Yuan Ruo-lan, Jiang Yu-tong, Peng Ye, Ye Jun-rui, Wang Sha-sha, Li Li-qing, Ruan Yuan, Li Pei-yi, Yan Xu, He Wen-bin, Li Gang, Chu Shi-feng*, Zhang Zhao*, Chen Nai-hong*
联系电话:
办公电话:010-63165182
Email:chushifeng@imm.ac.cn